Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


Trump to wrap up Xi summit with a tour of US archives
France to send military to protect Saudi Arabia, Macron says
Gaza facing world's worst economic crisis, says UNCTAD
At UN, Netanyahu defends Israel as delegates walk out
Trump welcomes Xi to Washington looking for a trade win
Malaysian ex-PM Najib asks court for stay of 15-year jail sentence
India's 'cockroach' party threatens protest if election chief doesn't quit in 48 hours
Russian strikes kill eight in Ukraine, damage maternity clinic
